Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

TDQS

A5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, idempotentHint, and destructiveHint false, and the description adds significant behavioral context beyond these: patents API sunset with soft-fail behavior, sources_used/sources_failed indicating real data availability, fda_products absence for small-molecule/generic-only companies explained as expected, and private company handling with explicit notes. No contradiction with annotations; the description enhances transparency significantly.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

While long, the description is densely packed with high-value information and each sentence earns its place. It front-loads purpose with examples, then systematically enumerates sources and return fields with clear separators (semicolons, parentheticals), and ends with parameter details. It is well-structured and not wasteful; the complexity of the tool justifies the length.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's high complexity (multiple sources, many return sections, no output schema), the description is remarkably complete. It details every return field (cik, company_name, recent_filings, fundamentals, patents, federal_contracts, fda_products, hiring, news, LEI, sources_used/failed), explains edge cases (resolved:false, empty sections, patent soft-fail), and provides parameter handling guidance. There is nothing an agent needs to know that is missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% for both parameters, providing baseline 3, but the description enriches meaning considerably: it gives concrete examples ('AAPL', '0000320193', 'Moderna'), explains name resolution via SEC EDGAR, clarifies that type accepts both values interchangeably, and details edge cases (private companies returning resolved:false). This goes well beyond the schema's enum and value descriptions, fully compensating for any ambiguity.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete example queries and states exactly what the tool does: 'full cross-source profile of a US public company in ONE parallel call.' It enumerates the specific data sources (SEC EDGAR, XBRL, USPTO, USAspending, FDA Purple Book, DOL LCA, GDELT/GNews, GLEIF) and return sections, making it unmistakable and distinct from sibling tools like deep_research or compare_entities. The explicit directive 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups' distinguishes it from alternative approaches.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides explicit when-to-use guidance: 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view.' It also clarifies usage edge cases: passing a ticker, CIK, or name; private companies returning resolved:false; patents soft-failing after sunset; and empty sections being 'real no-data, not a bug.' It implicitly signals when not to use it (for specific single-source queries) by contrasting with chained lookups.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation2/5

Multiple tools overlap heavily: ask_pipeworx, ask_pipeworx_beta (currently identical), and ask_pipeworx_grounded share the same routing core, while bet_research, polymarket_edges, polymarket_arbitrage, and polymarket_fill_risk all target prediction-market edge detection. The descriptions are detailed, but an agent must read a lot of nuance to avoid selecting the wrong tool.

Naming Consistency3/5

All names are lowercase snake_case and readable, but the convention is mixed: verb_noun names like encode_html and resolve_entity sit alongside bare verbs like remember and forget, and noun-phrase names like entity_profile, recent_changes, and polymarket_fill_risk. The ask_pipeworx_* and polymarket_* families are internally consistent, but there is no single predictable pattern across the whole set.

Tool Count2/5

At 33 tools this exceeds the 25+ threshold for a heavy set. The bloat is especially noticeable because the server is named Htmlentities yet only encode_html and decode_html relate to that purpose; the rest are unrelated Pipeworx research, prediction-market, memory, and subscription utilities.

Completeness4/5

The Pipeworx surface is broadly complete: ask/grounded/deep_research/discover/suggest cover data access, entity_profile/compare_entities/recent_changes/validate_claim cover entity workflows, and subscriptions and memory have create/list/delete lifecycles. Minor gaps such as no update operation for subscriptions or memories are workable, and encode/decode fully covers the literal Htmlentities purpose.